Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.56 -0.01 (-1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Other Accumulated Expenses (2020 - 2026)

Updated

Tenaya Therapeutics' Other Accumulated Expenses was $324,000 in Q2 2026, up 128.2% from $142,000 a year earlier but down 28.8% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Tenaya Therapeutics came in at $176,000, down 17.8% from FY2024.

  • Other Accumulated Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $214,000 in FY2024 (-55.2%), $478,000 in FY2023 (-12.3%), $545,000 in FY2022 (+236.4%) and $162,000 in FY2021 (+33.9%).
  • Quarterly Other Accumulated Expenses has moved between $142,000 (Q2 2025) and $833,000 (Q1 2024) over five years.
  • Compared with a year earlier, Other Accumulated Expenses was higher in two of the last eight quarters, with an average decline of 10.6%.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q4 2022 (growth of 236.4%); the worst was Q2 2024 (a decline of 63.8%).
  • Per Business Quant data, TNYA's Other Accumulated Expenses in the three quarters before Q2 2026 was $455,000 (Q1 2026), $176,000 (Q4 2025) and $186,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tenaya Therapeutics 125.57 Mn 125.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 324,000.00
Mar 31, 2026 455,000.00
Dec 31, 2025 176,000.00
Sep 30, 2025 186,000.00
Jun 30, 2025 142,000.00
Mar 31, 2025 350,000.00
Dec 31, 2024 214,000.00
Sep 30, 2024 435,000.00
Jun 30, 2024 282,000.00
Mar 31, 2024 833,000.00
Dec 31, 2023 478,000.00
Sep 30, 2023 458,000.00
Jun 30, 2023 778,000.00
Mar 31, 2023 677,000.00
Dec 31, 2022 545,000.00
Sep 30, 2022 485,000.00
Jun 30, 2022 588,000.00
Mar 31, 2022 791,000.00
Dec 31, 2021 162,000.00
Sep 30, 2021 514,000.00
API Access

Tenaya Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TNYA&period=max&api_key=YOUR_API_KEY